{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T02:33:38Z","timestamp":1790303618277,"version":"4.1.0"},"reference-count":50,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T00:00:00Z","timestamp":1742947200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Infect. Microbiol."],"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>This study assessed epidemiology characteristics, carbapenem-resistance genes, and drug resistance to ceftazidime-avibactam (CZA) and aztreonam-avibactam (AZA) in children with carbapenem-resistant <jats:italic>Klebsiella Pneumoniae<\/jats:italic> (CRKP) infections.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A total of 363 non-repetitive CRKP strains were collected from children who underwent two tertiary children\u2019s hospital between 1 January 2021 and 30 June 2024 in Chongqing and Kunming in Southwest China. Carbapenem resistance genes and antimicrobial susceptibility were analyzed. Basic clinical characteristics of the patients were obtained from medical records.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>bla<jats:sub>NDM-5<\/jats:sub>, bla<jats:sub>NDM-1,<\/jats:sub> and bla<jats:sub>KPC-2<\/jats:sub> were the predominant carbapenemase genes; their detection rates were 35.8%, 30.3%, and 25.3%, respectively. Patients in the KPC-2-producing <jats:italic>Klebsiella pneumoniae<\/jats:italic> (KPC-KP) (median age, 90 days) were older than those producing NDM-1 and NDM-5 <jats:italic>Klebsiella pneumoniae<\/jats:italic> (NDM-KP) (median age, 37 days) (<jats:italic>P &amp;lt; 0.05<\/jats:italic>). The detection rate of NDM-KP in the neonatal unit was higher compared with KPC-KP (62.5% vs. 9.8%, <jats:italic>P &amp;lt; 0.05<\/jats:italic>), while the detection rate of NDM-KP in the intensive care unit (ICU) was decreased compared with KPC-KP (9.6% vs. 40.2%, <jats:italic>P &amp;lt; 0.05<\/jats:italic>). NDM-KP had lower resistance rates to aminoglycosides and fluoroquinolones than KPC-KP; the resistance rate of aminoglycosides and fluoroquinolones among NDM-KP and KPC-KP in Chongqing was increased compared with Kunming. The sensitivity rates of KPC-KP to CZA and NDM-KP to AZA were 100%, and the MIC50 of the CRKP to CZA and AZA were 2 \u03bcg\/mL and 0.125\u03bcg\/mL, respectively.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>The epidemiological characteristics of Chinese children with CRKP infections, including the resistance genes and the antibiotic resistance of CRKP, exhibited significant variation between the two regions.KPC-KP strains had higher antimicrobial resistance in patients and thus should be given more attention in clinics and infection control.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fcimb.2025.1545999","type":"journal-article","created":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T10:19:19Z","timestamp":1742984359000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":13,"title":["Carbapenem-resistant Klebsiella pneumoniae infections in Chinese children: in vitro activities of ceftazidime-avibactam and aztreonam-avibactam against carbapenemase-producing strains in a two-center study"],"prefix":"10.3389","volume":"15","author":[{"given":"Xia","family":"Ran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunmei","family":"Jing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,3,26]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"105833","DOI":"10.1016\/j.ijantimicag.2019.10.014","article-title":"A systematic review and meta-analysis of treatment outcomes following antibiotic therapy among patients with carbapenem-resistant klebsiella pneumoniae infections","volume":"55","author":"Agyeman","year":"2020","journal-title":"Int. J. Antimicrobial Agents"},{"key":"B2","doi-asserted-by":"publisher","first-page":"e01426","DOI":"10.1128\/aac.01426-19","article-title":"). searching for the optimal treatment for metallo- and serine-\u03b2-Lactamase producing enterobacteriaceae: Aztreonam in combination with ceftazidime-avibactam or meropenem-vaborbactam","volume":"63","author":"Biagi","year":"2019","journal-title":"Antimicrobial Agents Chemotherapy"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1128\/aac.01076-18","article-title":"Past and present perspectives on \u03b2-lactamases","volume":"62","author":"Bush","year":"2018","journal-title":"Antimicrobial Agents Chemotherapy"},{"key":"B4","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/s1473-3099(18)30605-4","article-title":"Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the european economic area in 2015: a population-level modelling analysis","volume":"19","author":"Cassini","year":"2019","journal-title":"Lancet Infect. Dis."},{"key":"B5","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.jiph.2018.11.003","article-title":"Epidemiology of carbapenemase-producing enterobacteriaceae in a pediatric hospital in a country with high endemicity","volume":"12","author":"Castagnola","year":"2019","journal-title":"J. Infection Public Health"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.02290-21","article-title":"Multicenter genomic analysis of carbapenem-resistant klebsiella pneumoniae from bacteremia in China","volume":"10","author":"Cienfuegos-Gallet","year":"2022","journal-title":"Microbiol. Spectr."},{"key":"B7","volume-title":"Performance standards for antimicrobial susceptibility testing","year":"2024"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1128\/aac.02187-18","article-title":"Dose selection and validation for ceftazidime-avibactam in adults with complicated intra-abdominal infections, complicated urinary tract infections, and nosocomial pneumonia","volume":"63","author":"Das","year":"2019","journal-title":"Antimicrobial Agents Chemotherapy"},{"key":"B9","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.diagmicrobio.2006.07.004","article-title":"Emergence of serine carbapenemases (KPC and SME) among clinical strains of enterobacteriaceae isolated in the united states medical centers: report from the MYSTIC progra-2005)","volume":"56","author":"Deshpande","year":"2006","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"B10","volume-title":"v14.0. breakpoint tables for interpretation of MICs and zone diameters","year":"2024"},{"key":"B11","unstructured":"Surveillance atlas of infectious diseases\n          \n          2019"},{"key":"B12","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1038\/s41390-021-01745-7","article-title":"Neonatal multidrug-resistant gram-negative infection: epidemiology, mechanisms of resistance, and management","volume":"91","author":"Flannery","year":"2022","journal-title":"Pediatr. Res."},{"key":"B13","doi-asserted-by":"publisher","first-page":"e0028321","DOI":"10.1128\/Spectrum.00283-21","article-title":"Bacterial epidemiology and antimicrobial resistance profiles in children reported by the ISPED program in China, 2016 to 2020","volume":"9","author":"Fu","year":"2021","journal-title":"Microbiol. Spectr."},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics11060814","article-title":"Klebsiella pneumoniaeNosocomial outbreak of extensively\u00a0drug-resistant (Polymyxin b and carbapenem) in a collapsed university hospital due to COVID-19 pandemic","volume":"11","author":"Gaspar","year":"2022","journal-title":"Antibiotics (Basel Switzerland)"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1038\/s41564-024-01612-1","article-title":"Carbapenem-resistant klebsiella pneumoniae capsular types, antibiotic resistance and virulence factors in China: a longitudinal, multi-centre study","volume":"9","author":"Hu","year":"2024","journal-title":"Nat. Microbiol."},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1099\/jmm.0.001494","article-title":"Klebsiella pneumoniae Outbreak of KPC-producing ST15 strains in a chinese tertiary hospital: resistance and virulence analyses","volume":"71","author":"Huang","year":"2022","journal-title":"J. Med. Microbiol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.jhin.2012.10.012","article-title":"Impact of carbapenem resistance on the outcome of patients' hospital-acquired bacteraemia caused by klebsiella pneumoniae","volume":"83","author":"Hussein","year":"2013","journal-title":"J. Hosp. Infection"},{"key":"B18","doi-asserted-by":"publisher","first-page":"ovad107","DOI":"10.1093\/lambio\/ovad107","article-title":"Prevalence, antibiotic resistance profile, MBLs encoding genes, and biofilm formation among clinical carbapenem-resistant Enterobacterales isolated from patients in Mohammed VI University Hospital Centre, Morocco","volume":"76","author":"Ilham","year":"2023","journal-title":"Lett. Appl. Microbiol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"234","DOI":"10.3390\/antibiotics12020234","article-title":"Klebsiella pneumoniae Carbapenem-resistant : Virulence factors, molecular epidemiology and latest updates in\u00a0treatment options","volume":"12","author":"Karampatakis","year":"2023","journal-title":"Antibiotics (Basel Switzerland)"},{"key":"B20","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1099\/jmm.0.000921","article-title":"The clinical significance of carbapenem-resistant klebsiella pneumoniae rectal colonization in critically ill patients: from colonization to bloodstream infection","volume":"68","author":"Konstantina","year":"2019","journal-title":"J. Med. Microbiol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"895","DOI":"10.3389\/fmicb.2016.00895","article-title":"Global dissemination of carbapenemase-producing klebsiella pneumoniae: Epidemiology, genetic context, treatment options, and detection methods","volume":"7","author":"Lee","year":"2016","journal-title":"Front. Microbiol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"63","DOI":"10.3760\/cma.j.cn112150-20210812-00781","article-title":"[Analysis of molecular and clinical characteristics of carbapenem-resistant hypervirulent klebsiella pneumoniae in the intensive care unit]","volume":"56","author":"Lei","year":"2022","journal-title":"Zhonghua yu fang yi xue za zhi [Chinese J. Prev. Medicine]"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1016\/j.gpb.2022.02.005","article-title":"Genomic epidemiology of carbapenemase-producing klebsiella pneumoniae in China","volume":"20","author":"Li","year":"2022","journal-title":"Genomics Proteomics Bioinf."},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.02806-23","article-title":"). in vitro activity of ceftazidime-avibactam, imipenem-relebactam, aztreonam-avibactam, and comparators toward carbapenem-resistant and hypervirulent isolates","volume":"11","author":"Li","year":"2023","journal-title":"Microbiol. Spectr."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1128\/aac.04191-14","article-title":"In vitro susceptibility of characterized \u03b2-lactamase-producing strains tested with avibactam combinations","volume":"59","author":"Li","year":"2015","journal-title":"Antimicrobial Agents Chemotherapy"},{"key":"B26","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.jgar.2020.09.004","article-title":"Virulence evolution, molecular mechanisms of resistance and prevalence of ST11 carbapenem-resistant klebsiella pneumoniae in China: A review over the last 10 years","volume":"23","author":"Liao","year":"2020","journal-title":"J. Global Antimicrobial Resistance"},{"key":"B27","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1053\/j.semdp.2019.04.011","article-title":"Carbapenem-Resistant Enterobacteriaceae: An emerging bacterial threat","volume":"36","author":"Lutgring","year":"2019","journal-title":"Semin. Diagn. Pathol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.jinf.2009.01.010","article-title":"Outbreak of infections due to KPC-2-producing klebsiella pneumoniae in a hospital in crete (Greece)","volume":"58","author":"Maltezou","year":"2009","journal-title":"J. Infection"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.01537-18","article-title":"Evidence of sharing of klebsiella pneumoniae strains between healthy companion animals and cohabiting humans","volume":"57","author":"Marques","year":"2019","journal-title":"J. Clin. Microbiol."},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1128\/mSystems.00015-18","article-title":"Identification of pathogenicity-associated loci in klebsiella pneumoniae from hospitalized patients","volume":"3","author":"Martin","year":"2018","journal-title":"mSystems"},{"key":"B31","doi-asserted-by":"publisher","first-page":"S372","DOI":"10.1093\/cid\/civ730","article-title":"Bloodstream infections and frequency of pretreatment associated with age and hospitalization status in sub-saharan africa","author":"Nichols","year":"2015","journal-title":"Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. America"},{"key":"B32","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/s1473-3099(09)70054-4","article-title":"The real threat of klebsiella pneumoniae carbapenemase-producing bacteria","volume":"9","author":"Nordmann","year":"2009","journal-title":"Lancet Infect. Dis."},{"key":"B33","doi-asserted-by":"publisher","first-page":"S521","DOI":"10.1093\/cid\/ciz824","article-title":"Epidemiology and diagnostics of carbapenem resistance in gram-negative bacteria","volume":"69","author":"Nordmann","year":"2019","journal-title":"Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. America"},{"key":"B34","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.1080\/14656566.2019.1660772","article-title":"The latest advances in \u03b2-lactam\/\u03b2-lactamase inhibitor combinations for the treatment of gram-negative bacterial infections","volume":"20","author":"Papp-Wallace","year":"2019","journal-title":"Expert Opin. Pharmacotherapy"},{"key":"B35","doi-asserted-by":"publisher","first-page":"4275","DOI":"10.1128\/aac.02813-13","article-title":"High incidence and endemic spread of NDM-1-positive enterobacteriaceae in henan province, China","volume":"58","author":"Qin","year":"2014","journal-title":"Antimicrobial Agents Chemotherapy"},{"key":"B36","doi-asserted-by":"publisher","first-page":"i47","DOI":"10.1093\/jac\/dkaa497","article-title":"Role of new antibiotics for KPC-producing klebsiella pneumoniae","volume":"76","author":"Theuretzbacher","year":"2021","journal-title":"J. Antimicrobial Chemotherapy"},{"key":"B37","doi-asserted-by":"publisher","first-page":"87","DOI":"10.4103\/ijmr.IJMR21418","article-title":"Antimicrobial susceptibility profile & resistance mechanisms of global antimicrobial resistance surveillance system (GLASS) priority pathogens from india","volume":"149","author":"Veeraraghavan","year":"2019","journal-title":"Indian J. Med. Res."},{"key":"B38","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/s1473-3099(21)00399-6","article-title":"Clinical outcomes and bacterial characteristics of carbapenem-resistant klebsiella pneumoniae complex among patients from different global regions (CRACKLE-2): a prospective, multicentre, cohort study","volume":"22","author":"Wang","year":"2022","journal-title":"Lancet Infect. Dis."},{"key":"B39","doi-asserted-by":"publisher","first-page":"S196","DOI":"10.1093\/cid\/ciy660","article-title":"Phenotypic and genotypic characterization of Carbapenem-Resistant Enterobacteriaceae: Data from a longitudinal large-scale CRE study in chin-2016)","volume":"67","author":"Wang","year":"2018","journal-title":"Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. America"},{"key":"B40","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/s1473-3099(21)00425-4","article-title":"Regional differences in carbapenem-resistant klebsiella pneumoniae","volume":"22","author":"Wyres","year":"2022","journal-title":"Lancet Infect. Dis."},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1186\/s12941-017-0191-3","article-title":"Systematic review and meta-analysis of mortality of patients infected with carbapenem-resistant klebsiella pneumoniae","volume":"16","author":"Xu","year":"2017","journal-title":"Ann. Clin. Microbiol. Antimicrobials"},{"key":"B42","doi-asserted-by":"publisher","first-page":"S0195-6701(20)30130-4","DOI":"10.1016\/j.jhin.2020.03.031","article-title":"Actively surveillance and appropriate patients placements' contact isolation dramatically decreased Carbapenem-Resistant Enterobacteriaceae infection and colonization in pediatric patients in China","volume":"31","author":"Yin","year":"2020","journal-title":"J. Hosp. Infection"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/j.infpip.2021.100147","article-title":"Carbapenem-resistant enterobacterales colonization and subsequent infection in a neonatal intensive care unit in Shanghai, China","volume":"3","author":"Yin","year":"2021","journal-title":"Infection Prev. Pract."},{"key":"B44","doi-asserted-by":"publisher","first-page":"424","DOI":"10.3389\/fmicb.2016.00424","article-title":"Further Spread of bla NDM-5 in Enterobacteriaceae via IncX3 Plasmids in Shanghai, China","volume":"7","author":"Zhang","year":"2016","journal-title":"Front. Microbiol."},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1128\/aac.01882-17","article-title":"Epidemiology of Carbapenem-Resistant Enterobacteriaceae infections: Report from the China CRE network","volume":"62","author":"Zhang","year":"2018","journal-title":"Antimicrobial Agents Chemotherapy"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2024.107163","article-title":"Emergence of ceftazidime-avibactam resistance in bla KPC-33 -harbouring ST11 Klebsiella pneumoniae in a paediatric patient","volume":"63","author":"Zhou","year":"2024","journal-title":"Int. J. Antimicrobial Agents"},{"key":"B47","doi-asserted-by":"publisher","first-page":"96","DOI":"10.7883\/yoken.66.96","article-title":"Phenotypic and molecular characteristics of carbapenem-non-susceptible Enterobacteriaceae from a teaching hospital in Wenzhou, southern China","volume":"66","author":"Zhou","year":"2013","journal-title":"Japanese J. Infect. Dis."},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1099\/jmm.0.001482","article-title":"Surveillance of carbapenem-resistant in a paediatric hospital in China revealed the dynamics of carbapenemase and the prevalence of ST2735 K. pneumoniae","volume":"71","author":"Zhou","year":"2022","journal-title":"J. Med. Microbiol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"3563","DOI":"10.2147\/idr.S273989","article-title":"EnterobacteriaceaeIn vitro activity of ceftazidime-avibactam and aztreonam-avibactam against carbapenem-resistant isolates collected from three secondary hospitals in southwest China between 2018 and 2019","volume":"13","author":"Zou","year":"2020","journal-title":"Infection Drug Resistance"},{"key":"B50","doi-asserted-by":"publisher","first-page":"3017","DOI":"10.2147\/idr.S219635","article-title":"CP-CRE\/non-CP-CRE stratification and CRE resistance mechanism determination help in better managing CRE bacteremia using ceftazidime-avibactam and aztreonam-avibactam","volume":"12","author":"Zou","year":"2019","journal-title":"Infection Drug Resistance"}],"container-title":["Frontiers in Cellular and Infection Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2025.1545999\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T10:19:38Z","timestamp":1742984378000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2025.1545999\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,26]]},"references-count":50,"alternative-id":["10.3389\/fcimb.2025.1545999"],"URL":"https:\/\/doi.org\/10.3389\/fcimb.2025.1545999","relation":{},"ISSN":["2235-2988"],"issn-type":[{"value":"2235-2988","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,26]]},"article-number":"1545999"}}